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Extramedullary plasmacytoma is a rare plasma cell neoplasm that occurs in theabsence of systemic signs of multiple myeloma, and most often occurs in the upperaerodigestive tract of the head and neck.1 We report a case of extramedullaryplasmacytoma with immunoglobulin (Ig) D () in the chest wall and the subglottic
region that showed an interesting clinical course.
Clinical Summary
A 47-year-old woman visited our hospital with chief symptoms of a fist-sized tumor and
invariable pain in the left lateral pectoral region. The tumor was elastic and hard, with radiating
pressure pain. The chest radiograph showed an ill-defined 7.0  5.0-cm mass shadow in the left
lower lung field (Figure 1, A). The chest radiograph obtained during a mass chest radiograph
survey about 10 months before the visit appeared normal. Chest computed tomography demon-
strated a heterogeneously enhanced mass without destruction of the ribs in the left chest wall
(Figure 1, B). Magnetic resonance imaging showed no osteolytic lesion in the ribs. Preoperative
histopathologic diagnosis of the incisional biopsy sample was high-grade sarcoma.
The patient was scheduled for a chest wall resection and reconstructive surgery. On the day of
the operation, the anesthetist discovered a subglottic tumor while intubating the patient (Figure 2,
A). There had been no symptoms of dyspnea or change of voice before the operation. After a
tracheotomy, a chest wall dissection was performed, encompassing an area of 15.0  12.5 cm
starting from the lower edge of the seventh rib to the upper edge of the 11th rib. The defect of the
chest wall was reconstructed with polytetrafluoroethylene mesh and a skin flap.
The excised chest wall tumor, measuring 9.0  7.3  5.0 cm, surrounded ribs. Exami-
nation of a permanent section revealed that the chest wall tumor was IgD() type plasma-
cytoma. Ki-67 proliferation index (the proportion of proliferating cells in the tumor) of the
tumor showed a value of 40%. After the operation, M-protein was not detected in the blood
or urine. Bone marrow examination showed normal findings. The results of a radiographic
survey did not show any lesion.
Although biopsy had been performed several times on the subglottic tumor, we had
not been able to achieve a definite diagnosis. The subglottic tumor had regressed
spontaneously by about 10 weeks after the chest wall operation (Figure 2, B ). Two
months later, the patient was urgently readmitted to our hospital with the symptom of
airway stenosis caused by rapid regrowth of the subglottic tumor that reached the vocal
cord (Figure 2, C ). The subglottic tumor was identified as IgD( ) type plasmacytoma.
Systemic resurvey did not show any other lesions. The subglottic tumor was treated with
radiotherapy in doses of 50 Gy and one cycle of chemotherapy with vincristine, doxo-
rubicin, and dexamethasone. The subglottic tumor has been well controlled (Figure 2, D ).
The patient was successfully treated and shows no signs of recurrence or development of
multiple myeloma 7 years after this treatment.
Discussion
Extramedullary plasmacytomas in the chest wall are extremely uncommon. Most plasmacy-
tomas in the chest wall arise in bone.2
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In our case, the tumor in the chest showed a rapid growth
within about 10 months, and the regrowth tumor of the subglottic
region also showed a rapid growth within about 2 months. This
chest wall tumor showed a high proliferative index detected by
Ki-67. Although an elevated value of Ki-67 is considered to be a
poor prognostic factor in multiple myeloma, Galieni and col-
leagues3 postulated that extramedullary plasmacytoma has a dif-
ferent origin, and consequently different biologic behavior, than
multiple myeloma or plasmacytoma of the bone, with a more
favorable prognosis for extramedullary plasmacytoma.
Although the reason that the subglottic extramedullary plasma-
cytoma showed temporary but dramatic regression after the oper-
ation on the chest wall extramedullary plasmacytoma remains
unknown, we speculate that the regression may have interleukin
(IL) 6 implications. IL-6 is a potent myeloma cell growth factor
involved not only in vitro but also in vivo, and there is clear
evidence to support both autocrine and paracrine mechanisms of
IL-6 in myeloma.4 The subglottic tumor may have regressed after
the resection of the chest wall tumor because of the reduction of
the IL-6 signal. Another possible explanation for the regression
may have been nonsteroidal anti-inflammatory agent. Nonsteroidal
anti-inflammatory agents have been shown to inhibit the develop-
ment of plasmacytoma in a murine model.5 A nonsteroidal anti-
inflammatory agent used as an analgesic after operation may have
effected a temporary regression of the tumor.
We report a case of extramedullary plasmacytoma involving
the chest wall and the subglottic region characterized by IgD(),
rapid growth, and temporal spontaneous regression.
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Figure 1. A, Chest radiograph showing ill-defined mass shadow.
B, Chest computed tomographic scan showing soft-tissue density
mass without destruction of the ribs.
Figure 2. A, Bronchoscopy showing subglottic tumor during chest
wall resection surgery. A tube of 6 mm internal diameter was
used for intubation. B, Subglottic tumor reducing after operation
for chest wall tumor. C, Subglottic tumor shown to have regrown
rapidly within 2 months after chest resection procedure. Subglot-
tic tumor involving left-sided vocal cord almost obstructs airway.
D, Subglottic tumor has been controlled after chemoradiation
therapy.
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